Apple (AAPL) to Go All-In on 5G in 2022, Scraps New 4G Releases - Report
- Wall Street surges to all-time closing high on earnings, economic revival
- Was Intel's (INTC) Second Quarter a Speedbump or Inflection?
- Twitter (TWTR) Gains After Beating Q2 Estimates, Analysts Raise PTs as Brand Recovery Accelerates
- U.S. dollar on track for second week of gains; Fed meeting in focus
- Snap (SNAP) Surges 17% After Smashing Q2 Views Across the Board to Yield a Dozen Price Target Hikes
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Apple (NASDAQ: AAPL) is reportedly preparing to equip all 2022 iPhones with 5G capabilities, according to a report in Nikkei Asia.
The 2022 lineup will also include a revamp of its budget model iPhone SE with plans not to release any new 4G models next year. Apple also has no plans to introduce an updated version of the iPhone Mini next year.
"It is pretty much decided that there won't be a Mini next year, and there will be a relatively cost-effective version of the largest iPhone Pro Max instead. However, the designs for the detailed specifications for the four new models next year are not yet locked in," Nikkei Asia quoted a source.
Apple’s budget iPhone will have 5G capabilities due to Qualcomm's X60 chips while the unit will be powered by Apple's own A15 processor. According to Nikkei Asia, a new iPhone SE will look like a “refreshed version of the iPhone 8.” The most recent version of this model, released earlier this year, costs $399.
"We don't see revolutionary changes for Apple's iPhones next year. But with more models and better product planning, and specifications for next year, we do expect Apple's iPhone shipment could at least be in line with the global smartphone phone market recovery," said Jeff Pu, a senior analyst with Haitong International Securities.
Pu expects the Cupertino-based titan to ship 231 million iPhones this year and 240 million next year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Talkspace (TALK) on Watch on Chatter
- Gaotu Techedu (GOTU) has not received official notification of the regulations in China
- Meridian Bioscience (VIVO) to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
Create E-mail Alert Related CategoriesCorporate News, Rumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!